Table:
begin	end	state
1	1603	non-cytoplasmic

Input:
>WP_011382479.1
MEISAYLDRRIAELSEPLAKVGAGRLIRAYAAGIPLADLAEADPELVYGAALGLFAFLRD
RQPGAPSIRVFDPDLDRHGWVSSHSVVEIINDDMPFLVDSVAMELARRGIKVHLLVHPVL
RVDRDGAGTLVQVAANGSGSTPESVMHVEIDRQPAEVQTQLAESLAEVLAQVRLAVADWR
RMLETLWAGVTEFENASAKVPADEKQEALAFLEWLADNHFTFLGYRRFDLAKGVVADPAS
GLGILSDAGAHVFDDTVTLADMPAELRAFVQRPDPLMVTKSARHAVIHRPVRMDIIGLKQ
FDAKGKVVGLHAFLGLFTSAAYNDRPAQIPLLRRKIARVEARADFNKSGHDAKALINILE
TYPRDELFQVSEDALFEISIGILHLQDRQRVAVFLRNDEFERFVSCLVFVPRDRYDTPLR
LAVTAMLEEALGGTLDTFYTQVADLPLARLHFIIRTTPGHLRRVDALALEVRIADAARTW
HEHLQDALIQTHGEAAGLALARRWGKGFPASYRESHGALAAVADVGRIQTASGGDIVLNL
YRPVEAEPRQGRLKLYRSGQPVPLSGILPMLEAMGLVVIAEVPHEIEPDSGGSTVWIHDF
EVESADGAPLDVAERRELFHDALAAVWRGDADSDGFNRLVLSAGLSWREIMVLRAYTKYL
RQTGITYSQTYIEQALGGNADMATGLVRLFLASFDPKGRSGDASEAEAALLAGLDKVVSA
DDDRILRRFLNLIRSTLRTNYFQTDGAGKPKAYLSFKLDSRQVDDLPAPRPLVEVFVYSP
RVEAIHLRGGKVARGGIRWSDRREDFRTEILGLMKAQMVKNAVIVPVGAKGGFVVKKPPA
AGGREAYMAEGIECYKTLMRGLLDLTDNLVPEGVRPPPDVLRRDGDDPYLVVAADKGTAT
FSDIANAVSLEYGHWLGDAFASGGSQGYDHKKMGITAKGAWVAVERHFREMGIDTRSEDF
TVIGVGDMSGDVFGNGLLRSPHAKLVAAFNHAHIFLDPDPDPQKTFTERERLFNAVKAWP
DYDLSTISPGGGIWPRSAKSIPISPQAKARFGIEANSLTPTELIRTLLKAPVDLLFLGGI
GTYVKASGESNADAGDRANDTLRVNGSEVGARVVGEGANLGFTQLGRIEYAISGAGGGGG
RIDTDAIDNSAGVDCSDHEVNIKILVNDLVAAGDLTPKQRDKLLAEMTGEVGALVLRDNY
LQTQAISMLEAQGADLLDAEARFMRLLEKGGRLDRAIEFLPTDETLTERAARKQGFTRPE
LAVLLAYGKIWLYDHILASELPDDPFMAIDLTNYFPTQLRDRFGHEIQRHRLRREIVATV
VTNSIVNRVGGAFVSELMETTGHPPAQVARAYIVARDAFRMREVWRAIEELDGKVPAAAQ
TAMQNEANRLVERATLWVLRSMPSPFALGAGISELSPGVKALEGAVPAILPPDAAAAVLA
RIDHFVGQGVPHDLAQRVGNLIVLASAADILRIATRQNLSIETAGRLYFAVGARFSLGWL
RASAEKLSGRGHWLKLAAAAAIEDLYGHQRDITSVVAASYPDLEPDAAVQAWLEANRAAV
ERAETLLAELKAASHIDLSMIMVANRQLRTLTESGVAVSGGNG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server